LP(A) LEVELS IN PATIENTS UNDERGOING AORTOCORONARY BYPASS-SURGERY

被引:18
作者
AVERNA, MR
BARBAGALLO, CM
OCELLO, S
DORIA, O
DAVI, G
SCAFIDI, V
ALBIERO, R
NOTARBARTOLO, A
机构
[1] UNIV PALERMO,IST MED INTERNA & GERIATR,CATTEDRA PATOL MED,I-90134 PALERMO,ITALY
[2] OSPED CIVICO,DIV CARDIOCHIRURG,PALERMO,ITALY
关键词
AORTOCORONARY BYPASS; LIPIDS; APOPROTEINS; LP(A);
D O I
10.1093/oxfordjournals.eurheartj.a060074
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aims of this study were to evaluate plasma lipid, apoprotein and Lp(a) levels in patients with severe coronary atherosclerosis undergoing aorto-coronary bypass surgery (BP) and to relate these parameters to the involvement of one or more vessels. Seventy-seven male patients and 77 cardiovascular disease-free controls, matched for sex, age and body weight were studied. Higher triglyceride and apo B levels with lower HDL-cholesterol and apo A-I levels were found in BP patients in comparison with the controls. Lp(a) levels were slightly, but not significantly, increased. Moreover BP patients presented a significantly higher prevalence of HDL-cholesterol levels below 35 mg dl-1 (49·3% vs 22·1%) and Lp(a) levels above 70mg dl-1 (10·4% vs 1·3%) than the controls. When patients were divided according to the number of coronary vessels involved (one, two or three), no significant difference was found, with a trend to increase in Lp(a) mean levels and in prevalence of Lp (a) levels above 30 and 70 mg dl-1 in more severely diseased patients.These results suggest that patients with severe coronary artery disease undergoing aorto-coronary bvpass surgery show low HDL-cholesterol levels with high triglyceride levels. Moreover Lp(a) levels above 70 mg dl-1 are highly associated with severe coronary vessel stenosis. © 1992 The European Society of Cardiology.
引用
收藏
页码:1405 / 1409
页数:5
相关论文
共 38 条
[1]  
ALBERS JJ, 1977, J LIPID RES, V18, P331
[2]   THE ASSOCIATION BETWEEN SERUM LP(A) CONCENTRATIONS AND ANGIOGRAPHICALLY ASSESSED CORONARY ATHEROSCLEROSIS - DEPENDENCE ON SERUM LDL LEVELS [J].
ARMSTRONG, VW ;
CREMER, P ;
EBERLE, E ;
MANKE, A ;
SCHULZE, F ;
WIELAND, H ;
KREUZER, H ;
SEIDEL, D .
ATHEROSCLEROSIS, 1986, 62 (03) :249-257
[3]   EPIDEMIOLOGY [J].
AUSTIN, MA ;
GOTO, Y ;
LENFANT, C ;
TYROLER, HA .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (03) :A22-A25
[4]  
AVERNA MR, 1989, METABOLISM, V38, P1
[5]  
AVOGARO P, 1979, LANCET, V1, P901
[6]  
BARBIR M, 1988, BRIT HEART J, V60, P397
[7]   STANDARDIZATION OF IMMUNOCHEMICAL QUANTITATION OF HUMAN APOLIPOPROTEIN-A AND APOLIPOPROTEIN-B [J].
BECKER, W ;
SCHAFER, W ;
ZIEGENBEIN, W .
RICERCA IN CLINICA E IN LABORATORIO, 1980, 10 (01) :203-212
[8]  
BERG K, 1963, ACTA PATHOL MIC SC, V59, P369
[9]   THE RELATION OF RISK-FACTORS TO THE DEVELOPMENT OF ATHEROSCLEROSIS IN SAPHENOUS-VEIN BYPASS GRAFTS AND THE PROGRESSION OF DISEASE IN THE NATIVE CIRCULATION - A STUDY 10 YEARS AFTER AORTOCORONARY BYPASS-SURGERY [J].
CAMPEAU, L ;
ENJALBERT, M ;
LESPERANCE, J ;
BOURASSA, MG ;
KWITEROVICH, P ;
WACHOLDER, S ;
SNIDERMAN, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (21) :1329-1332
[10]  
CARLSON LA, 1985, ACTA MED SCAND, V218, P207